Approximately 30% of the pediatric patients with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) harbor a somatic heterozygous loss-of-function alteration in PAX5 [4]. The gene discussed is PAX5; the disease is acute lymphoblastic leukemia.